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Introduction

Acute pulmonary embolism (PE) is a common diagnosis that can lead to death if left untreated. Computerized tomography pulmonary angiogram scan (CTPA) is the gold standard
for diagnosis of PE. Utilization of CTPA is increasing in the emergency setting even when
suspicion for PE is very low. While CTPA is helpful, radiation exposure, contrast reactions,
and cost must be considered. D-dimer is a well-established, high sensitivity and low specificity laboratory test that can effectively rule out PE in low-risk patients when negative. The
ADJUST-PE trial showed that there is a natural rise of D-dimer levels with age. This age adjusted D-dimer level is meant to prevent unnecessary CTPA exams in low suspicion patients.
We hypothesize that there are a significant amount of unwarranted CTPA exams ordered at
our community hospital that would not have been performed if the age adjusted D-dimer
level were implemented.
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Methods

During a four-month period we collected a list of patients 18 years of age and older who
received a CTPA exam for initial evaluation of possible acute PE at our institution. The
primary outcome was to evaluate the percentage of patients who received an imaging study
despite a negative D-dimer collected prior to the study, using the age adjusted upper limit
of normal based on the ADJUST-PE study.

Results

There were 734 CTPA exams that met our criteria in a four-month period. D-dimer levels were checked in 30.38% (223 of 734) of cases prior to imaging. Out of these 223 cases, 21.08% (47 of 223) were found to have negative age adjusted D-Dimer levels yet still
received an imaging study. Out of these 47 cases, 44% (21 of 47) would have been positive
using the traditional D-dimer threshold.

Conclusion

This study demonstrates that by adherence to the guideline-based pre-test algorithm and
also utilizing the recommendations set forth by the ADJUST-PE study, approximately 21%
of patients who undergo D-dimer testing would avoid unwarranted CT imaging. In addition
to decreased radiation and contrast exposure, a significant amount of health care expense
would be saved.
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Introduction

Acute pulmonary embolism (PE) is the third
most common cause of cardiovascular death,
following acute coronary syndrome and stroke,

attributing to approximately 100,000 deaths
per year in the United States (US). PE is also
the second most common cause of sudden
unexpected death following acute coronary
syndrome in outpatients.1,2 The incidence rate
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for the first episode of acute PE is 1 to 2 per
1,000 each year, with a rising incidence correlating directly to age, reaching 5 per 1,000 each
year by the age of 80.3
The diagnosis of PE has more than doubled
with the advent of the readily available computerized tomography pulmonary angiogram
(CTPA) scan,3 which is considered the gold
standard technique.4 As the greatest fraction
of imaging services is performed for older
patients,5 this upward trend can be expected
to further increase as the baby-boomer generation enters retirement. To contribute further
to the rising incidence of CTPA scans, studies
have found that emergency clinicians hold a
low threshold when deciding to order a CTPA
even when the suspicion for PE is low in very
low risk populations, possibly due to the legal
consequences of missing a diagnosis.6-9
However helpful CTPA scans may be, they are
not without their limitations including cost,
contrast exposure and radiation exposure.
Along with the increased frequency of imaging,
the cost has also risen at about twice the rate
of other health care technologies.10 Contrast
reactions must be taken into consideration
when ordering a PE protocol. Acute reactions
to contrast varies from 15% for mild reactions
to 0.2% for severe reactions.11,12 Additionally,
radiation exposure is always of concern as it
carries with it an increased risk of developing
neoplasms.9,13 Medical imaging contributes to
over 50% of the average total radiation dose to
US residents today compared to less than 25%
in 1980.14 Given the rising incidence, increasing
cost, increased imaging utilization, medical side
effects and an aging population with significant associated morbidity/mortality rates, this
diagnosis has an ever-increasing health care
burden.
Dr. Philip Wells, of the University of Ottawa,
developed a validated algorithm called the
“Wells Criteria” that differentiates patients
suspected to have acute PE based on low or
high probability, utilizing a negative D-dimer
level to effectively rule out PE in the low probability group without the need for CTPA.15,16
However, studies have shown that the D-dimer
increases with age due to comorbid conditions,16-20 thus limiting the yield and cost-effectiveness of the test in older patients while
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simultaneously promoting the overuse of CT
imaging.15,21
Subsequently, the ADJUST-PE study demonstrated that due to the natural rise of D-dimer
levels with age, an adjusted upper limit of
normal (age ×10 ug/L with a lower limit of 500
ug/L) was equally effective in ruling out PE
without further imaging in patients over the
age of 50, safely excluding a larger percentage
of at risk patients from undergoing unnecessary imaging.15,16
The goal of this retrospective study is to improve imaging stewardship by utilizing the age
adjusted D-dimer to effectively rule out pulmonary emboli without the need for imaging in
a community-based hospital. We hypothesize
that there are a significant amount of unwarranted CT angiography-pulmonary embolism
(CTA-PE) protocols ordered based on a D-dimer that is within normal limits based on the
ADJUST-PE study.

Methods

At Memorial Health University Medical Center,
a 612-bed academic medical center, we collected a list of all patients requiring CTA chestPE protocols for a four-month period drawn
between January 1 and April 30, 2017. Based
on medical record numbers, all CTA chest-PE
protocols from this time period were reviewed
utilizing the picture archiving and communication system (PACS) (n=768). If the radiologist’s
original final read was not clearly positive or
negative, these studies were independently
reviewed by an additional board-certified radiologist at the time of data collection (n=99).
Additionally, if the exam quality was commented upon (i.e., body habitus, poor bolus timing,
motion artifact), these were also submitted for
independent review. The primary outcome was
to evaluate the percentage of patients who
received an imaging study despite a negative
D-dimer collected prior to the study, using the
age adjusted upper limit of normal based on
the ADJUST-PE study.

Inclusion Criteria

All patients 18 years and older who were admitted to the hospital and received a CTA-PE
protocol for initial evaluation of possible acute
PE at MHUMC from January 1 to April 30, 2017
were included in the study.
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Exclusion Criteria

The following patients were excluded from the
study: patients who were undergoing imaging
to re-evaluate a recent diagnosis of an acute
PE (within the last 6 months), patients 17 years
or younger and patients with known thrombus
(i.e., DVT, upper extremity thrombus, etc.). Additionally, patients with non-diagnostic exams
were excluded.
An exam was deemed to be non-diagnostic for
this study if the central or segmental pulmonary branches were unable to be cleared of
PE; this decision was made based on the 2016
CHEST guidelines, which determined that
sub-segmental PEs are not typically clinically
significant and anticoagulation treatment is
argued against.22

Results

Overall, there were 768 CTA chest-PE protocols obtained in the initial study. Of these, 99
(13.48%) were reviewed by a second board-certified diagnostic radiologist and 34 were excluded, making the final included patient count

734. (Figure 1) The average age of patients
undergoing CTA-chest PE protocol was 55.45
years old. Of the total CTPA scans, 11.17% (82 of
734) were positive for acute PE. Of the positive
acute PE cases, the average D-dimer was 6475
ug/L. D-dimer levels were checked in 30.38%
(223 of 734) of cases prior to imaging. Of these
223 cases, 21.08% (47 of 223) were found to
have negative age-adjusted D-dimer levels yet
still received an imaging study. Out of these 47
cases, 44% (21 of 47) would have been positive
using the traditional threshold of 500ug/L
without utilizing the age-adjusted D-dimer
criteria. There were no false negative D-dimer
cases in this study.

Discussion

Our study found that 44% of patients (n=21)
with a positive D-dimer would have otherwise
been negative if providers utilized the age-adjusted D-dimer as set forth by the ADJUST-PE
trial, ultimately avoiding unwarranted imaging
and improving health care savings. Furthermore, there were 26 cases that received a
CTPA despite having a negative D-dimer based

768 CTPA protocols
reviewed
34 exclusions
11 segmental bolus
10 chronic PE
9 follow-up imaging
2 <18 years old
1 subclavian thrombus
1 right atrial thrombus
734 total inclusions

511 no D-dimer
(69.62%)
64 (+) CT (12.52%)

223 D-dimer
(30.38%)
176 positive AA
D-dimer (78.92%)

47 negative AA
D-dimer (21,08%)

18 (+) CT (10.22%)

0 (+) CT (0%)

Figure 1. Results showing a reduction in CT scans using age-adusted D-dimer levels.
AA=age adjusted
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on the traditional cutoff of 500ug/L. This
represents a total of 47 patients, or 21% of patients in a 4-month period who still received diagnostic CTPA imaging despite being screened
negative with the age-adjusted D-dimer, a
highly sensitive screening tool.
This study demonstrates the contrast between
the well-studied, guideline-based algorithms
and the actual clinical practice of diagnosing
PE. By improving the adherence to the guideline–based pre-test algorithm, and also utilizing recommendations set forth according to
the ADJUST-PE study, approximately 21% of
patients who undergo D-dimer testing would
avoid unwarranted CT imaging and contrast
exposure. Additionally, a significant amount
of health care expense would be saved. As of
2020, a CTA chest at this institution is priced at
$4,851 according to MHUMC’s publically available detailed price report, not including specialist fees that are billed separately. Extrapolating
these 47 patients with a negative AA D-dimer
who underwent imaging over 12 months, this
represents $911,988 in potential annual health
care savings not including specialist fees.
There are several limitations of this study. This
study could not determine a patient’s pretest probability; therefore, patients were not
stratified into risk groups based upon clinical
suspicion by risk stratification tools such as the
Wells criteria or PERC rule. This also is a retrospective study and did not prospectively enroll
patients; only a subset of patients underwent
D-dimer testing who underwent diagnostic imaging. This study also didn’t evaluate patients
with clinical suspicion of PE who did not undergo CTPA imaging

Conclusion

Despite multiple extensive studies that validate
pre-test probability, the utilization of CTPA
remains high. This study illustrates that 21%
of patients underwent unwarranted imaging
based on the ADJUST-PE analysis. When this
data is extrapolated over 12 months, approximately 188 patients at our community hospital will undergo unwarranted imaging with
potential annual healthcare waste upwards
of $900,000. With rising health care burden,
limiting unnecessary imaging has strong implications when accounting for cost of imaging,
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length of stay, complication rates and incidental findings. The application of this study is to
raise awareness to improve imaging stewardship and overall patient care in the local setting. As an example, The European Respiratory
Journal has updated their guidelines for diagnosis and management of acute PE to include
use of age adjusted D-dimer cut-offs.23 In the
future, we hope that there will be widespread
adherence to a clinical decision making algorithm that uses the age-adjusted D-dimer that
will aid physicians in navigating the increasingly
complex diagnostic work up and accurate ordering of appropriate imaging modalities.
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